皇冠管理端登3网站（www.99cx.vip）:Pharmaniaga to ride on high demand for its products

博彩平台网址大全（www.99cx.vip）是一个开放皇冠体育网址代理APP下载、皇冠体育网址会员APP下载、皇冠体育网址线路APP下载、皇冠体育网址登录APP下载的官方平台。博彩平台网址大全上博彩平台网址大全登录线路、博彩平台网址大全代理网址更新最快。博彩平台网址大全开放皇冠官方会员注册、皇冠官方代理开户等业务。

MIDF Research said the group has increased its profitability in the last few months as demand for pharmaceutical products continued to rise well into the second half of the year.

KUALA LUMPUR: Pharmaniaga Bhd is expected to post positive earnings in financial years 2022 (FY22) and FY23 as demand for pharmaceutical products continues to increase.

In a note, MIDF Research said the group has increased its profitability in the last few months as demand for pharmaceutical products continued to rise well into the second half of the year.

“Despite having no problems with raw materials, Pharmaniaga has stated that the high demand has caused manufacturing to go beyond 100% capacity, and paracetamol production had increased to more than twice the normal capacity.

“Liquid drugs are also facing a demand and supply imbalance, as such, Pharmaniaga’s Indonesian plants have been requested to deliver the syrups,” the research house pointed out.

,

皇冠管理端登3网站皇冠管理端登3网站（www.99cx.vip）实时更新发布最新最快最有效的皇冠管理端登3网站手机网址,包括新2登3手机网址,新2登3备用网址,皇冠登3最新网址,新2足球登3网址,新2网址大全。

,

MIDF Research also added that Pharmaniaga’s logistics segment will be renewing its concession agreement with the government in the fourth quarter of 2022, assuring a steady order of drugs for public hospitals in the near term.

Additionally, the group’s efforts to push its brands to become household names could reset the public sentiment that only certain brands of drugs would give out the same effect, hence boosting its future income.

“We are also optimistic on its vending machine venture which is part of the pharmaceutical sector’s solution to accessibility and digital healthcare,” it said. — Bernama

转载说明:本文转载自Sunbet。